Financials Braskem S.A. Nyse

Equities

BAK

US1055321053

Commodity Chemicals

Market Closed - Nyse 21:00:02 14/05/2024 BST 5-day change 1st Jan Change
7.57 USD +3.42% Intraday chart for Braskem S.A. -3.81% -14.17%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 24,521 19,504 45,482 19,609 17,347 15,693 - -
Enterprise Value (EV) 1 60,375 59,264 84,361 19,609 73,323 55,764 53,740 49,864
P/E ratio -8.49 x -2.8 x 3.28 x -56.4 x -3.8 x -5.8 x 14.2 x 5.39 x
Yield 2.82% - 14.1% - - - - 4.83%
Capitalization / Revenue 0.47 x 0.33 x 0.43 x 0.2 x 0.25 x 0.2 x 0.19 x 0.18 x
EV / Revenue 1.15 x 1.01 x 0.8 x 0.2 x 1.04 x 0.72 x 0.65 x 0.58 x
EV / EBITDA 16.9 x 5.4 x 2.44 x 1.85 x 19.6 x 8.17 x 5.26 x 4.09 x
EV / FCF -145 x 16.8 x 7.42 x - -10.8 x 14.3 x 9.26 x 6.44 x
FCF Yield -0.69% 5.96% 13.5% - -9.28% 6.99% 10.8% 15.5%
Price to Book 4.86 x -8.52 x 5.83 x - 4.36 x 6.94 x 3.47 x 2.25 x
Nbr of stocks (in thousands) 795,742 795,744 796,066 796,303 796,968 796,968 - -
Reference price 2 29.85 23.57 57.63 23.76 21.86 19.50 19.50 19.50
Announcement Date 04/04/20 11/03/21 16/03/22 22/03/23 19/03/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 52,324 58,543 105,625 96,519 70,569 77,360 82,904 85,468
EBITDA 1 3,576 10,975 34,507 10,571 3,737 6,825 10,217 12,181
EBIT 1 -57 -72 26,044 5,838 -1,469 1,238 5,074 7,323
Operating Margin -0.11% -0.12% 24.66% 6.05% -2.08% 1.6% 6.12% 8.57%
Earnings before Tax (EBT) 1 -4,803 -9,684 17,961 47 -6,192 -3,918 632.1 2,798
Net income 1 -2,798 -6,692 14,000 -336 -4,579 -2,779 685.3 2,828
Net margin -5.35% -11.43% 13.25% -0.35% -6.49% -3.59% 0.83% 3.31%
EPS 2 -3.515 -8.407 17.57 -0.4215 -5.746 -3.364 1.378 3.619
Free Cash Flow 1 -417.2 3,533 11,365 - -6,802 3,900 5,806 7,737
FCF margin -0.8% 6.03% 10.76% - -9.64% 5.04% 7% 9.05%
FCF Conversion (EBITDA) - 32.19% 32.94% - - 57.14% 56.82% 63.51%
FCF Conversion (Net income) - - 81.18% - - - 847.11% 273.59%
Dividend per Share 2 0.8404 - 8.145 - - - - 0.9427
Announcement Date 04/04/20 11/03/21 16/03/22 22/03/23 19/03/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 28,212 26,731 25,411 25,387 18,990 19,446 17,756 16,676 16,691 17,920 18,225 18,186 17,972 - -
EBITDA 1 7,682 4,845 3,927 1,967 -168 1,063 703 921 1,049 - 1,832 1,770 1,974 2,566 2,649
EBIT 1 3,722 3,844 1,654 691 -1,599 -167 -601 -364 -337 -89 469.2 320.7 575.7 - -
Operating Margin 13.19% 14.38% 6.51% 2.72% -8.42% -0.86% -3.38% -2.18% -2.02% -0.5% 2.57% 1.76% 3.2% - -
Earnings before Tax (EBT) 1 1,248 5,018 -1,738 -1,005 -2,227 144.2 -1,480 -3,030 -1,827 -2,071 -1,769 -840.7 -492.7 - -
Net income 1 500 3,884 -1,406 -1,103 -1,710 184 -771 -2,418 -1,575 -1,345 -1,292 -660.7 -414.3 - -
Net margin 1.77% 14.53% -5.53% -4.34% -9% 0.95% -4.34% -14.5% -9.44% -7.51% -7.09% -3.63% -2.31% - -
EPS 2 0.6659 4.879 -1.764 -1.384 -2.153 0.2309 -0.9674 -3.034 -1.975 -1.688 -1.621 -0.8288 -0.5197 0.5800 0.7800
Dividend per Share 2 8.145 - - - - - - - - - - - - - -
Announcement Date 16/03/22 11/05/22 10/08/22 09/11/22 22/03/23 08/05/23 09/08/23 09/11/23 19/03/24 09/05/24 - - - - -
1BRL in Million2BRL
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 35,855 39,760 38,879 - 55,976 40,071 38,047 34,171
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 10.03 x 3.623 x 1.127 x - 14.98 x 5.871 x 3.724 x 2.805 x
Free Cash Flow 1 -417 3,533 11,365 - -6,802 3,900 5,806 7,737
ROE (net income / shareholders' equity) -47.9% -499% 494% - -62.4% -122% 26.7% 65.6%
ROA (Net income/ Total Assets) -4.39% -8.68% 15.7% - -3.93% -2.13% 0.88% 2.65%
Assets 1 63,672 77,110 89,420 - 116,523 130,756 77,792 106,915
Book Value Per Share 2 6.140 -2.770 9.880 - 5.010 2.810 5.610 8.650
Cash Flow per Share 2 2.850 7.910 18.50 - -2.850 1.420 7.950 6.830
Capex 1 2,683 2,760 3,421 - 4,530 2,353 2,963 3,431
Capex / Sales 5.13% 4.71% 3.24% - 6.42% 3.04% 3.57% 4.01%
Announcement Date 04/04/20 11/03/21 16/03/22 22/03/23 19/03/24 - - -
1BRL in Million2BRL
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
19.5 BRL
Average target price
28.38 BRL
Spread / Average Target
+45.51%
Consensus